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1. Introduction
  Pterocarpus erinaceus (P. erinaceus) Poir. which belongs to 
the family Fabaceae, is a tree usually up to 8  and 15 m in 
height.  This plant grows in savannah and is endemic from 
West Africa to Central Africa[1]. In savannah, P. erinaceus
is a medicinal plant used to heal various diseases. In 
central region of Burkina Faso, its stem bark is used to 
treat inflammatory affections such as ulcer, rheumatism, 
dermatitis and infections. Recently, several studies 
demonstrated the antimalarial activity, antimicrobial 
activity and antiprogestative activity of  P. erinaceus[2-4]. 
Earlier, phytochemical investigations revealed the 
presence of some isoflavonoids as prunetin, muningin, 
afromosin, tectorigenin, pseudobaptigenin isolated from 
heartwood of P. erinaceus[5]. Research on relationship 
between antioxidants and prevention of some diseases, 
such as cancer, cardiovascular and other inflammatory 
affections has been increasingly sharply in recent years[6]. 
The role of free radicals and reactive oxygen species is 
becoming recognized in the pathogenesis of the human 
diseases including cancer, aging and atherosclerosis[7]. 
Objective: To screen methanol and dichloromethane extracts of stem bark of Pterocarpus 
erinaceus for anti-inflammatory, analgesic, in vitro antioxidant activities and phytochemical 
analysis. Methods: Anti-inflammatory activity was determined by using carrageenan induced-
edema of mice paw and croton oil-induced edema of mice ear; analgesic effect was evaluated 
using acetic acid-induced writhing. Phytochemical screening of extracts was performed by thin 
layer chromatography. The chromatographic fractionation led to the isolation of main active 
components as friedelin, lupeol and epicathechin.  The structures were established by TLC and 
nuclear magnetic resonance studies. Results: Both methanol and dichloromethane extracts, 
friedelin, lupeol and epicatechin showed a significant anti-inflammatory effect using croton oil 
induced-ear edema. Furthermore, the action of dichloromethane extract was more important. 
At the doses of 100 and 200 mg/kg, the methanol extract was able to reduce the carrageenan 
induced-hind paw edema, while at the doses of 100, 200 and 400 mg/kg, it showed an important 
analgesic effect against writhing induced by acetic acid injection of 38.8%, 68.0% and 74.3%, 
respectively. Antioxidative properties of methanol extract and its dichloromethane and ethyl 
acetate fractions were assessed by using the 1,1-diphenyl-2-picrylhydrazyl method. The 
methanol extract showed the stronger radical scavenging activity than dichloromethane and ethyl 
acetate fractions, with an antiradical power of 5, 3.5 and 2 respectively. The main components 
isolated from these extracts as friedelin, lupeol and epicathechin were responsible of these 
activities. Conclusions: The results suggest that the stem bark extracts of Pterocarpus erinaceus 
possessed important anti-inflammatory, analgesic activities and strong antioxidant properties, 
therefore, they could be used as natural potential ingredients for pharma ceutical industry.
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However, synthetic chemicals such as non-steroidal anti-
inflammatory drugs (NSAID) were widely used against 
inflammatory disorders. Unfortunately, the digestive 
iatrogenic pathology caused by the use of these non-
steroidal anti-inflammatory drugs constitutes a serious 
problem of public health because of its frequency and its 
gravity. Therefore, the use of natural antioxidants, plant 
phytochemicals, fruits, vegetables and medicinal plants 
is important and less damaging to the human health 
and environment [8]. To the best of our knowledge, the 
anti-inflammatory, analgesic and antioxidant effects of
P. erinaceus have not been  reported before and therefore 
the main objectives of this study are to assess the anti-
inflammatory, analgesic and antioxidant activities of the 
stem bark extracts of this plant and to determine the main 
active components.
2. Materials and methods
2.1. Plant material
  The stem barks of P. erinaceus Poir. were collected in 
March 2007 from Gourcy, Burkina Faso. The plant was 
authenticated by Dr. Adjirma Thombiano from Section of 
Botany, UFR SVT of Ouagadougou University. The voucher 
specimens (N° ON 01) have been deposited in the herbarium 
of Ouagadougou University. 
 
2.2. Animals
  The NMRI mice (24-37 g) were obtained from the animal 
house of Department of “Médecine-pharmacopée/
Pharmacie” of the Institute of Health Sciences Research. 
The room temperature was maintained at (22依2)℃ with 
the 12 h light/12h dark cycle. The mice were starved 17 
hours before the experiments. The tests, in this work, were 
performed according to the protocols already approved by 
the Institute of Health Sciences Research (Burkina Faso) 
and met the international standards of animal study[9].
2.3. Chemicals
  Acetic acid, carrageenan, 1, 1-diphenyl-2-picrylhydrazyl 
(DPPH), neocuproïn (2,9-dimethyl-1,10-phenanthroline) 
were purchased from Sigma (Sigma, St Louis,USA). 
Ammonium acetate buffer (Prolabo, France), trolox 
(Fluka, France) and chlorogenic acid (Acros, France) 
were used in this work. Paracetamol, hydrocortisone and 
ketamine hydrochloride (Rotexmedica, Trittau, Germany) 
were provided by Hospital “Yalgado Ouédraogo” of 
Ouagadougou. All solvents were analytical grade.
2.4. Extraction and isolation
  The dried and committed stem barks of P. erinaceus 
Poir. (661 g) were successively extracted by maceration 
with dichloromethane (8 L) and methanol (10 L) at room 
temperature for 48 h. The extracts were concentrated 
to dryness under reduced pressure at 40℃ to yield 
dichloromethane (DCM) crude (3.5 g) and a methanol (MeOH) 
residue (100 g). Both the extracts were dried and stored at 
4℃ until use.
  The DCM crude (1.5 g) was fractionated by column 
chromatography over silica gel (40-63 毺m, Merck), eluted 
with n-hexane/CH2Cl2 gradient (from 5/5 to 0/10, v/v), with 
CH2Cl2/ ethyl acetate gradient (from 5/5 to 0/10, v/v) and 
afforded thirteen fractions (A to M). The fraction B was purified 
by column chromatography over silica gel (40-63 毺m,
Merck), eluting with n-hexane/ethyl acetate gradient (10/0 
to 7/3, v/v) and yielded the compound 1 (25 mg) and three 
other fractions. The fraction D was subjected to solid phase 
extraction (SPE) over silica gel (40-63 毺m, Merck) to yield 
compound 2 (6 mg) by using n-hexane/ethyl acetate (0/10 to 
7/3, v/v) as gradient. 
  The MeOH residue (36 g) was suspended in water (600 mL) 
during 20 hours, and partitioned with CH2Cl2 (3伊200 mL) and 
ethyl acetate (3伊200 mL) to yield a CH2Cl2 fraction (0.10 g) 
and an ethyl acetate fraction (1.03 g). Ethyl acetate fraction 
was fractionated by column chromatography over Sephadex 
LH-20 (Pharmacia) as stationary phase and MeOH as eluent 
and afforded eight fractions (A.1 to A.8). The fraction A.3 was 
re-chromatographied on silica gel (40-63 毺m, Merck) with 
n-hexane/ethyl acetate (6/4 to 0/10, v/v)  as gradient and 
yielded the compound 3 (27 mg).
  On the other hand, the screening of the chemical constituents 
was carried out with the extracts of the P. erinaceus 
stem barks, using chemical reagents and thin layer 
chromatography (TLC) methods according to the methodology 
suggested by Wagner and Bladt[10].
2.5. Anti-inflammatory activity
2.5.1. Carrageenan induced paw edema test
  the test was carried out according to Winter[11] with the 
MeOH extract. One hour  prior to injection of carrageenan, 
the mice were orally treated with MeOH extract (100 and 200 
mg/kg bw) and distilled water, and then four other groups 
received MeOH extract at doses of  50, 100 and 200 mg/kg 
and hydrocortisone (10 mg/kg) at intraperitoneal. The edema 
volume was recorded at 1 h, 3 h and 5 h after carrageenan 
injection using plethysmometer (model Ugo Basil, n° 7141, 
Italy). The average volume of the right hind paw of each 
mouse was calculated from three reading. The inhibitory 
activity was calculated according to the following formula: 
%Inhibitian = 
(Ct-C0) control-(Ct-C0) treated
(Ct-C0) control
伊100
 
        
  Ct is the paw circumference at time t, C0 is the paw 
circumference before carrageenan injection, Ct – C0 
is edema, (Ct – C0) control is edema or paw size after 
carrageenan injection to control mice at time t.
2.5.2. Ear edema induced by oil croton
  Topical inflammation was carried out according to 
Sawadogo[12] with slight modification. NMRI mice were 
anaesthetized with ketamine hydrochloride (150 mg/kg, i.p.). 
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Coetaneous inflammation was induced by applying 5 毺L of 
solution of croton oil dissolved in 42% aqueous ethanol and 
the sample (MeOH extract, compound 3 and hydrocortisone) 
or in DCM (DCM extract, compound 1 or 2) on the inner 
surface of the right ear. Control mice received only irritation 
solution. Six hours later, mice were sacrificed and a plug
(7 mm Ø) was removed from both the treated (right) and the 
untreated (left) ears. Edematous response was measured 
as the weight difference between the two plugs. The anti-
inflammatory activity was expressed as percent reduction of 
edema in treated mice compared with the control mice.
2.6. Analgesic activity
  Acetic acid-induced writhing test: the intraperitoneal 
injection of 0.6% acetic acid solution (10 mL/kg bw) 
provoked abdominal writhing[13]. Five groups of six mice 
each have formed. The mice orally received the MeOH 
extract (100, 200 and 400 mg/kg), paracetamol (100 mg/kg) 
and distilled water 1 h before acetic acid injection. Five 
min after acetic acid injection, the number of writhing was 
recorded during 15 min. The analgesic effect was evaluated 
by a percentage reduction of writhes in treated mice 
compared to those in the control group.
2.7. DPPH free radical scavenging method
  The method of Brand[14] was used to evaluate the 
antioxidant power of the extracts. 20 毺L of each extract 
solution at different concentrations was mixed with 200 毺L
DPPH methanolic solution (0.08 mg/mL) in a 96-
well microtitre plate. After 30 min incubation at room 
temperature, the absorbance was measured at 515 nm. 
Trolox and chlorogenic acid were used as standard control. 
Each determination was carried out in triplicate. The 
percentage of residual DPPH was evaluated onto the graph in 
function of quantity of antioxidant: 
    %DPPHres= f(antioxidant quantity/DPPH quantity)
  Antiradical activity was defined as the amount of 
antioxidant necessary to decrease the initial DPPH 
concentration by 50% and expressed as antiradical power 
(ARP = 1/EC50).
2.8. Statistical analysis
  The results were expressed as mean暲SEM. The data were 
analyzed using GraphPad Prism version 5.0. The statistical 
analysis was performed by one way ANOVA followed by 
Dunnett’s test. At P<0.05 the differences were considered 
significant compared to control group.
3. Results 
3.1. Chemical composition
  The phytochemical screening on TLC revealed the presence 
of tannins, flavonoids and phenolic compounds in the MeOH 
and ethyl acetate fraction. Thus in the dichloromethane 
extract triterpenoids were detected.
  The screening indicated that the non-polar compounds 
such as triterpenoids were extracted from the plant material 
during maceration into the DCM extract. Both, the MeOH 
extract and ethyl acetate fraction contained compounds as 
flavonoids, tannins and phenolic compounds. In generally, 
TLC analysis of the DCM fraction revealed the presence 
of friedelin and lupeol as main active constituents while 
the analysis of the MeOH extract and ethyl acetate fraction 
revealed the presence of epicatechin as their main active 
constituent. Friedelin 1 and lupeol 2 were isolated from 
dichloromethane extract. These triterpenes were identified 
by their 1H NMR and 13C NMR data using Bruker DRX 300 
by comparison with those of the literature data[15,16]. The 
compound 3 from ethyl acetate fraction was (-) epicatechin. 
This flavanol was identified with its 1H NMR and 13C NMR 
spectra compared with those of literature data[17]. 
  Friedelin (1): TLC: Silica (Hexane/ethyl acetate, 90/10), Rf= 
0.42. Spot: yellow with sulfuric vanillin, physical aspect: 
white powder. 
  1H NMR: (300 MHz, CDCl3) δ 7.27 (s, 1H), 5.31 (s, 1H), 2.40-
2.36 (m, 2H), 2.30-2.23 (m, H), 2.18 (s, 1H), 1.98 (ddd, J=9.8, 
5.8, 3.4 Hz, 3H), 1.75 (s, 7H), 1.62 (dd, J=7.9, 4.8 Hz, 4H), 
1.58-1.48 (m, 17H), 1.41-1.22 (m, 36H), 1.19 (s, 9H), 1.06 (s, 
9H), 1.01 (d, J=1.9 Hz, 17H), 0.96 (s, 9H), 0.89 (d, J=5.8 Hz, 
18H), 0.73 (s, 9H).
  13C NMR: (75 MHz, CDCl3) δC 22.26 (C 1), 41.50 (C 2), 213.23 
(C 3), 58.19 (C 4), 42.12 (C 5), 41.26 (C 6), 18.21 (C 7), 52.65 (C 8), 
37.41 (C 9), 59.44 (C 10), 35.59 (C 11), 30.48 (C 12), 39.66 (C 13), 
38.26 (C 14), 32.38 (C 15), 35.98 (C 16), 29.96 (C 17), 42.75 (C 18), 
35.31 (C19), 28.14 (C 20), 32.73 (C 21), 39.23 (C 22), 6.80 (C 23), 
14.63 (C 24), 17.92 (C 25), 20.24 (C 26), 18.64 (C 27), 31.06 (C 28), 
35.01 (C 29), 31.76 (C 30)(Figure 1).
Figure 1.  Friedelin.
  Lupeol (2): TLC: Silica (CH2CL2 100%), Rf =0.57. Spot: 
purple with sulfuric/vanillin, white powder.
  1H NMR: (300 MHz, CDCl3) (300 MHz, CDCl3) δ 7.26 (s, 1H), 
4.80-4.48 (m, 2H), 3.21 (s, 2H), 2.48-2.35 (m, 1H), 2.00-1.87 
(m, 3H), 1.74-1.53 (m, 16H), 1.46-1.23 (m, 18H), 1.08 (dd, 
J=16.7, 11.1 Hz, 5H), 1.03 (s, 3H), 1.00 (s, 2H), 0.97 (d, J=3.1 
Hz, 5H), 0.94 (s, 5H), 0.91 (s, 1H), 0.87 (s, 2H), 0.83 (s, 3H), 
0.81-0.78 (m, 5H), 0.76 (s, 3H) .
  13C NMR: (75 MHz, CDCl3) δ 38.73 (C 1), 27.46 (C 2), 79.01 (C 
3), 38.87 (C 4), 55.32 (C 5), 18.33 (C 6), 34.31 (C 7), 40.85 (C 8), 50.46 
(C 9), 37.19 (C 10), 20.95 (C 11), 25.17 (C 12), 38.08 (C 13), 42.85 (14), 
27.44 (C 15), 35.60 (C 16), 43.01 (C 17), 48.33 (C 18), 48.00 (C 19),
150.96 (C 20), 29.87 (C 21), 40.02 (C 22), 28.00 (C 23), 15.37(C 24), 
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16.12 (C 25), 15.99 (C 26), 14.56 (C 27), 18.01 (C 28), 109.33 (C 29), 
19.32 (C 30) (Figure 2).
Figure 2. Lupeol.
 (-)-epicatechin (3): TLC: silica RP-18 (MeOH/H2O, 50/50), 
Rf=0.34. Spot: yellow with NEU (DBA), physical aspect: yellow 
powder. [毩D] = - 46° (C=0.19, MeOH). 
  1H NMR (300 MHz, MeOD) δ 6.96 (s, 1H), 6.77 (d, J=4.9 Hz, 
2H), 5.92 (dd, J=7.9, 2.0 Hz, 1H), 4.81 (s, 1H), 4.17 (s, 1H), 
3.45-3.13 (m, 3H), 2.79 (ddd, J=19.5, 16.8, 3.7 Hz, 2H), 2.15 
(s, 1H), 1.28 (s, 1H). 
  13CNMR: (75MHz,CDCl3) δ 79.59 (C 2), 67.21 (C 3), 28.99 ( C 
4), 157.6 (C 5), 96.09(C 6), 158.1 (C 7), 95.78 (C 8), 157.0 (C 9), 
99.76 (C 10), 132.01 (C 1’), 115.59 (C 2’), 145.50 (C3’), 145.66 
(C 4’), 115.03 (C 5’), 119.10 (C 6’) (Figure 3).
Figure 3.  Epicatechin.
3.2. Anti-inflammatory activity 
3.2.1.Carrageenan induced paw edema test
  The effects of MeOH extract on carrageenan induced-paw 
edema in mice have been shown in Table 1. At different 
doses, the oral and the intraperitoneal administration of 
MeOH extract inhibited significantly the edema induced by 
carrageenan injection. At doses 50, 100 and 200 mg/kg its 
intraperitoneal administration reduced dose-dependently 
the paw edema (Table 1).
3.2.2. Ear edema induced by oil croton
  At the doses of 50, 100 and 200 毺g/ear, DCM extract caused 
inhibition with 32.3%, 69.7% and 91.7%, respectively. 
The MeOH extract reduced the edema by 42.0% and 85.4% 
at the doses of 300 and 500 毺g/ear. Friedelin 1 (100 毺g/
ear), lupeol 2 (100 毺g/ear), epicatechin 3 (75 毺g/ear) and 
hydrocortisone (100 毺g/ear) caused inhibition percentage of 
61.1%, 48.2%, 16.9% and 62.0%, respectively (Figure 4).
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Figure 4. Effect of MeOH extract (A)and CH2Cl2 extract (B) on ear 
edema induced by oil croton.
3.3. Acetic acid-induced writhing test
  The writhing induced by acetic acid injection was reduced 
by the MeOH extract. At doses of 100, 200 and 400 mg/kg 
oral administration of this extract exhibited an inhibition 
of 38.8% 68.0% and 74.3%, respectively (Table 2). The 
reference product (paracetamol) caused a more important 
inhibition than the MeOH extract at same dose (47.36%).
3.4. DPPH free radical scavenging method
  Table 3 showed the free radical-scavenging capacity of 
MeOH extract and its dichloromethane and ethyl acetate 
Table 1
Effect of administration of MeOH extract on carrageenan induced hind paw edema.          
Samples
  Doses 
(mg/kg bw) 
Increase in paw volume (mL) Edema inhibition (%)
1 h 3 h 5 h 1 h 3 h 5 h
Oral  administration Control -         0.21依0.02      0.24依0.03    0.28依0.03 - - -
MeOH extract 100         0.15依0.04*  0.18依0.04* 0.16依0.05**  28.57 25.00 42.86
200    0.10依0.03**    0.13依0.04** 0.10依0.02** 52.38 45.83 64.28
i.p. administration Control -         0.24依0.03                  0.34依0.01        0.37依0.06 - - -
MeOH extract 50         0.14依0.02**              0.29依0.04         0.24依0.04*   41.67       14.70 35.13
100         0.10依0.02**          0.26依0.04**   0.20依0.03**  58.33       23.53 45.94
200    0.08依0.03**         0.23依0.04**    0.17依0.03** 66.67       32.35 54.05
Hydro cortisone 10         0.19依0.02                0.28依0.04**  0.25依0.06** 20.83       17.65 32.43
*P<0.05, **P<0.001 significant from control (one way ANOVA analysis followed by Dunnett’s test).
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fractions. The MeOH extract had the most important 
antiradical power compared to its fractions and the standard 
antioxidants (trolox and chlorogenic acid).
4. Discussion
  The paw edema induced by carrageenan is an experiment 
animal model used to evaluate the acute anti-inflammatory 
activity of natural substances and drugs. The carrageenan 
injection provokes the activation of mast cells and the 
release of chemical mediators. The release of mediator 
involves three phases, first phase lasted for 1 hour that 
mediated by histamine, serotonin and the second phase was 
due to release of bradykinin during 2-3 hours;  prostaglandins 
were produced during the last phase (4-6 h)[18]. The MeOH 
extract inhibited the inflammatory response during the 
three phases of edema. At doses of 100 and 200 mg/kg, the 
oral administration of MeOH extract caused an important 
inhibition of paw edema induced by carrageenan injection. 
The maximal inhibition was noted at fifth hour oral 
administration (64.28% at 200 mg/kg). It suggests that the 
oral administration could more inhibit the prostaglandins 
biosynthesis. However, the intraperitoneal administration 
could reduce more the production of histamine and serotonin 
because it showed the maximal inhibition during the first 
phase (65.21% at 200 mg/kg).
  The inflammatory response produced by application of 
croton oil was reduced by the MeOH and DCM extracts, 
friedelin 1, lupeol 2 and epicatechin 3. The croton oil 
application in inner of ear of mice is the model tested to 
essay the topical anti-inflammatory effect of some drugs[19]. 
The ear edema induced by croton oil application is due to 
the production of some cytokines such as TNF 毩, IL1毬 and 
others pro-inflammatory products[20,21]. The DCM extract 
presented the highest inhibition compared to hydrocortisone, 
friedelin, lupeol and epicatechin. The high inhibition of 
DCM extract was due to the apolarity of extract and the 
products it contains. The reduction of ear edema induced by 
croton oil application could be due to the action of extracts 
and compounds on the release of cytokines.
  Friedelin and lupeol contributed to the anti-inflammatory 
activity of DCM extract. Lupeol is known to possess the anti-
inflammatory activity[22-24], the ability to inhibit cytokines 
such as TNF毩, IFN毭, IL2, IL4[25] and analgesic effect 
against glutamate-induced nociception[26], while friedelin is 
able to delay the release of nitric oxide[27].  Epicatechin was 
able to inhibit the production of nitric oxide[28]. These three 
compounds that were responsible of biological effect had not 
been isolated before from P. erinaceus.
  The writhing induced by injection of acetic acid is the 
experimental animal model used to test the peripheral 
analgesic effect of some substances and NSAIDs. Acetic 
acid injection provokes the release of substance P, 
histamine, serotonin and prostaglandins which stimulated 
the nociceptives neurons[29,30]. Ours results show that the 
oral administration of MeOH extract was able to inhibit 
significantly the writhing induced by acetic acid injection. 
The treatment with MeOH extract has been observed to 
indicate dose-dependent inhibition. The analgesic effect of 
MeOH extract may be the inhibition of release of cytokines 
and pro-inflammatory mediators such as prostaglandins.
  The free radicals such as reactive oxygen species (ROS) are 
produced during the process of inflammation by the mast 
cells, neutrophils and macrophages. This production of 
ROS contributes to expand the inflammatory response[31,32]. 
The present results indicate that methanol extract and 
its fractions inhibited significantly DPPH free radical. It 
suggests that these extracts might inhibit the release of free 
radicals during the inflammation. This antioxidant ability of 
the extracts contributes to reinforce the anti-inflammatory 
and analgesic effects.
  The present study is the first report to provide data about 
the anti-inflammatory, analgesic and antioxidant activities 
of the MeOH and DCM extracts obtained from the stem barks 
of P. erinaceus commonly used in Burkina Faso as folk 
medicine. In summary, the anti inflammatory, analgesic and 
antioxidant activities of the MeOH extract were better and 
stronger than those of DCM extract. But both  the extracts 
showed the same anti inflammatory potency to inhibit the 
ear edema of mouse induced by croton oil application. 
Interestingly, the main active compounds isolated from 
these extracts as friedelin, lupeol and epicatechin contribute 
to these activities. Possible synergetic actions of other 
components in the extracts could be taken in consideration. 
P. erinaceus can also represent a useful source of anti-
inflammatory, analgesic and antioxidative constituents, 
which could be easily isolated by the non-polar solvent 
dichloromethane and the polar solvent methanol. Therefore, 
it is suggested that further works should be performed on 
isolation and identification of the active constituents of 
the MeOH extract of the plant. These results may provide a 
starting point for the investigations to explore new natural 
anti inflammatory, analgesic and antioxidant products. 
P. erinaceus can be considered as a promising natural 
source of ingredients that could be used in food and in 
pharmaceutical industry. This study has provided the 
Table 2
Effect of oral administration of MeOH extract on writhing induced by 
acetic acid (mean暲SEM, n=6).
Samples Doses (mg/kg bw) Number of writhing 
Control -            66.17依2.00 
100 40.50依1.80**
MeOH extract 200 20.17依2.00**
400 17.00依3.00** 
Paracetamo 100 34.83依1.47**
** P <0.001 significant from control (one way ANOVA analysis 
followed by Dunnett’s test ).
Table 3
DPPH radical scavenging capacity of MeOH extract, DCM fraction 
and  ethyl acetate fraction.
Samples  IC50  (mg/mg DPPH) ARP
MeOH extract      0.20依0.02 5
DCM fraction    0.50依0.04 2
Ethyl acetate  fraction   0.28依0.05 3.57
Chlorogenic acid                    0.27依0.03 3.70
Trolox   0.22依0.01 4.55
ARP(Antiradical power)=1/ IC50.
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scientific data to promote the traditional medicine and 
confirmed the use of this plant by the healers to treat 
inflammatory diseases. 
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